CDP323
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for CDP323, covering 2011-09-12 to 2011-09-12. Get the full timeline:
Most recent: Clinical Trial Update: Placebo Controlled Study in Subjects With Relapsing Forms of MS to Evaluate the Safety, Tolerability and Effects of CDP323 [Phase 2]